Free Trial

Genocea Biosciences (GNCAQ) Competitors

Genocea Biosciences logo

GNCAQ vs. SCPS, VAXX, AMPE, NAVB, EVLO, CMRA, GNCA, ARDS, STAB, and EFTR

Should you be buying Genocea Biosciences stock or one of its competitors? The main competitors of Genocea Biosciences include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Ampio Pharmaceuticals (AMPE), Navidea Biopharmaceuticals (NAVB), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry.

Genocea Biosciences vs. Its Competitors

Genocea Biosciences (NASDAQ:GNCAQ) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genocea BiosciencesN/AN/AN/AN/AN/A
Scopus BioPharmaN/AN/A-$11.61MN/AN/A

Company Net Margins Return on Equity Return on Assets
Genocea BiosciencesN/A N/A N/A
Scopus BioPharma N/A N/A N/A

In the previous week, Genocea Biosciences' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score.

Company Overall Sentiment
Genocea Biosciences Neutral
Scopus BioPharma Neutral

Genocea Biosciences has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.19, meaning that its share price is 119% less volatile than the S&P 500.

Summary

Genocea Biosciences beats Scopus BioPharma on 1 of the 1 factors compared between the two stocks.

Get Genocea Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNCAQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

GNCAQ vs. The Competition

MetricGenocea BiosciencesBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$6K$273.10M$5.71B$9.51B
Dividend YieldN/AN/A4.60%3.99%
P/E RatioN/AN/A28.0720.02
Price / SalesN/A364.35459.47103.02
Price / CashN/A22.4436.5558.97
Price / BookN/A12.118.615.88
Net IncomeN/A-$106.40M$3.24B$258.50M

Genocea Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009
VAXX
Vaxxinity
N/A$0.00
flat
N/A-56.0%$13KN/A0.0090Gap Up
AMPE
Ampio Pharmaceuticals
N/A$0.01
flat
N/A+145.5%$11KN/A0.0020Gap Down
NAVB
Navidea Biopharmaceuticals
N/A$0.00
-50.0%
N/A-50.0%$10K$8.13K0.0010
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume
CMRA
Comera Life Sciences
N/A$0.00
flat
N/AN/A$6K$1.00M0.002
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
ARDS
Aridis Pharmaceuticals
N/AN/AN/AN/A$5KN/A0.0030Gap Up
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020Negative News
EFTR
eFFECTOR Therapeutics
0.073 of 5 stars
$0.00
-50.0%
N/A-99.6%$1KN/A0.0010Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:GNCAQ) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners